Literature DB >> 8012694

Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission.

Z Y Wang1, S R Tung, G R Strichartz, R Håkanson.   

Abstract

1. Three non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, were found to inhibit the electrically-evoked, tachykinin-mediated contractile responses of the rabbit iris sphincter in a concentration-dependent fashion; the pIC50 values were 5.6 +/- 0.01, 5.4 +/- 0.07 and 4.8 +/- 0.03, respectively. 2. These antagonists also inhibited the electrically-evoked, parasympathetic response of the rabbit iris sphincter and the sympathetic response of the guinea-pig vas deferens in a concentration-dependent manner; the pIC50 values were 0.3-1.2 log units lower than those recorded for the tachykinin-mediated responses. 3. Two local anaesthetics, bupivacaine and oxybuprocaine, were also found to inhibit the tachykinin-mediated, cholinergic and sympathetic contractile responses in these tissues in a concentration-dependent manner; the concentration ranges for producing the inhibition were similar to those of the non-peptide tachykinin receptor antagonists. 4. On the sciatic nerves of frogs, the tachykinin receptor antagonists inhibited action potentials in a concentration-dependent manner; the potency of the three drugs was similar to that of bupivacaine. 5. Our results suggest that, in addition to blocking tachykinin receptors, the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, may exert non-specific inhibitory effects on neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012694      PMCID: PMC1910036          DOI: 10.1111/j.1476-5381.1994.tb14041.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

Review 1.  Molecular anatomy and molecular design of channel proteins.

Authors:  M Montal
Journal:  FASEB J       Date:  1990-06       Impact factor: 5.191

2.  Pharmacological properties of a potent and selective nonpeptide substance P antagonist.

Authors:  C Garret; A Carruette; V Fardin; S Moussaoui; J F Peyronel; J C Blanchard; P M Laduron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

3.  Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors.

Authors:  J W Constantine; W S Lebel; H A Woody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

4.  Role of NK1 tachykinin receptors in thermonociception: effect of (+/-)-CP 96,345, a non-peptide substance P antagonist, on the hot plate test in mice.

Authors:  A Lecci; S Giuliani; R Patacchini; G Viti; C A Maggi
Journal:  Neurosci Lett       Date:  1991-08-19       Impact factor: 3.046

5.  Neurokinin receptors in the rabbit iris sphincter characterised by novel agonist ligands.

Authors:  J M Hall; D Mitchell; I K Morton
Journal:  Eur J Pharmacol       Date:  1991-06-18       Impact factor: 4.432

6.  The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.

Authors:  S Guard; S J Boyle; K W Tang; K J Watling; A T McKnight; G N Woodruff
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Antagonists that demonstrate species differences in neurokinin-1 receptors.

Authors:  K C Appell; B J Fragale; J Loscig; S Singh; B E Tomczuk
Journal:  Mol Pharmacol       Date:  1992-04       Impact factor: 4.436

8.  Synthesis and substance P antagonist activity of naphthimidazolium derivatives.

Authors:  K B Lawrence; B R Venepalli; K C Appell; R Goswami; M E Logan; B E Tomczuk; J M Yanni
Journal:  J Med Chem       Date:  1992-04-03       Impact factor: 7.446

9.  Stereoselective inhibition of neuronal sodium channels by local anesthetics. Evidence for two sites of action?

Authors:  S Lee-Son; G K Wang; A Concus; E Crill; G Strichartz
Journal:  Anesthesiology       Date:  1992-08       Impact factor: 7.892

10.  Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist.

Authors:  C Advenier; N Rouissi; Q T Nguyen; X Emonds-Alt; J C Breliere; G Neliat; E Naline; D Regoli
Journal:  Biochem Biophys Res Commun       Date:  1992-05-15       Impact factor: 3.575

View more
  10 in total

1.  Investigation of the specificity of FK 888 as a tachykinin NK1 receptor antagonist.

Authors:  Z Y Wang; S R Tung; G R Strichartz; R Håkanson
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

2.  Inhibition of bradykinin-evoked trigeminal nerve stimulation by the non-peptide bradykinin B2 receptor antagonist WIN 64338 in vivo and in vitro.

Authors:  J M Hall; M Figini; S K Butt; P Geppetti
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.

Authors:  D T Beattie; I J Beresford; H E Connor; F H Marshall; A B Hawcock; R M Hagan; J Bowers; P J Birch; P Ward
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat.

Authors:  E Cellier; L Barbot; S Iyengar; R Couture
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.

Authors:  J Culman; B Wiegand; H Spitznagel; S Klee; T Unger
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

6.  An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.

Authors:  K Ren; M J Iadarola; R Dubner
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

7.  Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.

Authors:  W S Lee; S M Moussaoui; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

8.  Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord.

Authors:  B A Chizh; M J Cumberbatch; P J Birch; P M Headley
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

9.  Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.

Authors:  M Malcangio; N G Bowery
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

10.  Nitric oxide induces acetylcholine-mediated contractions in the guinea-pig small intestine.

Authors:  L Barthó; R Lefebvre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.